课题基金 / 基金详情

SYNTHESIS AND ASSESSMENT OF ANTI-CANCER AND ANTI-ANGIOGENIC ACTIVITY OF FUSARAOC

SYNTHESIS AND ASSESSMENT OF ANTI-CANCER AND ANTI-ANGIOGENIC ACTIVITY OF FUSARAOC
FUSARAOC抗癌和抗血管生成活性的合成与评价
批准号:
7959476
负责人:
ELAHE MAHDAVIAN
金额:
$2.45万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-05-01 至 2010-04-30

项目摘要

项目成果

ELAHE MAHDAVIAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Fusarochromanone (FC-101a) is a flavonoid produced by the mold, Fusarium equiseti. Lee et al. first isolated and determined the structure of this molecule (without stereochemistry) via NMR and mass spectrometry. FC-101a is distinguished from other known chromanone natural products by the unique arrangement of the alternating ¿-keto-amine functionality along its upper face and the two geminal methyl groups at C(2). The absolute stereochemistry at C(3') is defined as 3'-R, according to the Cahn-Inglold-Prelog convention. The side chain, is important to the molecule's biological activity (described below). Acetylation of the C(3') amine, for example, drastically reduces the molecule's potency in biological studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DEVELOPMENT OF NOVEL ANTI-CANCER AGENTS BASED ON FUSAROCHROMANONE
DEVELOPMENT OF NOVEL ANTI-CANCER AGENTS BASED ON FUSAROCHROMANONE
SYNTHESIS AND BIOLOGICAL - ACTIVITY ASSESSMENT OF FUSAROCHROMANONE AMIDE ANALOGS
FUSARAOCHROMANONE: NEW ANALOGS AS POTENTIAL ANTICANCER AND ANTIANGIOGENIC AGENTS
海外基金